Long-term follow-up and late complications of CAR-T cell therapy

Background: Chimeric antigen receptor T-cell (CAR-T cell) therapy has transformed the treatment landscape for relapsed or refractory hematologic malignancies. As the number of long-term survivors continues to grow, the recognition and management of late complications have become critical clinical priorities. The existing literature remains fragmented, with limited long-term prospective data and a lack of unified follow-up guidelines. Methods: A narrative review of the literature was conducted using PubMed, MEDLINE, and Google Scholar databases from inception through April 2026. Key search terms included long-term follow-up, survivorship, late effects, CAR-T cell therapy, chimeric antigen receptor, late complications, delayed cytopenias, hypogammaglobulinemia, secondary malignancies, immune reconstitution, and screening. This review synthesizes available evidence with expert consensus recommendations. Results: The review identifies prolonged cytopenias, hypogammaglobulinemia and infectious complications as the most prevalent late effects. Secondary myeloid neoplasms occur with a shorter latency than historically observed after conventional chemotherapy. Neurocognitive deficits following immune effector cell-associated neurotoxicity syndrome generally resolve within six months. Cardiovascular, endocrine, and reproductive late effects are emerging areas of concern with limited specific data. Conclusion: Structured, long-term, multidisciplinary follow-up is essential for CAR-T cell therapy recipients. This review provides recommendations for the long-term surveillance and management of these patients. Prospective registries and standardized screening protocols are urgently needed.

Authors

Institutions

Publication Details

Journal
JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
Published
2026-11-20
DOI
https://doi.org/10.46765/2675-374x.2025v7n1e333
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Long-term follow-up and late complications of CAR-T cell therapy

Karine Sampaio Nunes Barroso, Giancarlo Fatobene
2 links
JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
CAR-T cell therapy research
article

Long-term follow-up and late complications of CAR-T cell therapy

Karine Sampaio Nunes Barroso, Giancarlo Fatobene
article en

Abstract

Background: Chimeric antigen receptor T-cell (CAR-T cell) therapy has transformed the treatment landscape for relapsed or refractory hematologic malignancies. As the number of long-term survivors continues to grow, the recognition and management of late complications have become critical clinical priorities. The existing literature remains fragmented, with limited long-term prospective data and a lack of unified follow-up guidelines. Methods: A narrative review of the literature was conducted using PubMed, MEDLINE, and Google Scholar databases from inception through April 2026. Key search terms included long-term follow-up, survivorship, late effects, CAR-T cell therapy, chimeric antigen receptor, late complications, delayed cytopenias, hypogammaglobulinemia, secondary malignancies, immune reconstitution, and screening. This review synthesizes available evidence with expert consensus recommendations. Results: The review identifies prolonged cytopenias, hypogammaglobulinemia and infectious complications as the most prevalent late effects. Secondary myeloid neoplasms occur with a shorter latency than historically observed after conventional chemotherapy. Neurocognitive deficits following immune effector cell-associated neurotoxicity syndrome generally resolve within six months. Cardiovascular, endocrine, and reproductive late effects are emerging areas of concern with limited specific data. Conclusion: Structured, long-term, multidisciplinary follow-up is essential for CAR-T cell therapy recipients. This review provides recommendations for the long-term surveillance and management of these patients. Prospective registries and standardized screening protocols are urgently needed.

JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPYVol. 7(1)
Universidade de São Paulo (BR), Hospital Universitário Walter Cantídio (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Good health and well-being
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Long-term follow-up and late complications of CAR-T cell therapy — Karine Sampaio Nunes Barroso, Giancarlo Fatobene · JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY (2026) | TGRS Research Map | TGRS